Principle investigator
Prof. Sina M. Coldewey, MD, PhD
Head
Phone: +49 3641 9-396530
Medical career
| Since 09/2020 | Head of the Division of Anaesthesiology, Clinic for Anaesthesiology and Intensive Care Medicine, Jena University Hospital (UKJ) |
| 2019 | Certification of intensive care medicine in the field of anaesthesiology |
| 2017 - 2020 | Senior consultant /interim head of the Divison of Anaesthesiology , Clinic for Anaesthesiology and Intensive Care Medicine (Director: Prof. M. Bauer), UKJ (http://www.kai.uniklinikum-jena.de/) |
| Since 2017 | Representative for qualification and education at the Clinic for Anaesthesiology and Intensive Care Medicine, UKJ, Organisation of postgraduate continuing medical education |
| Since 2014 | Senior consultant, Clinic for Anaesthesiology and Intensive Care Medicine, UKJ (Director: Prof. K. Reinhart) |
| 2010 - 2014 | Senior Registrar/Scientific Associate, Clinic for Anesthesiology and Intensive Care, Hannover Medical School (MHH) |
| 2010 | General Medical Council, Certificate of Full Registration as Medical Practitioner with Specialist Registration |
| 2010 | Specialist Certification in Anesthesiology, Germany |
| 2008 | Specialist Certification in Emergency Medicine, Germany |
| 2005 - 2010 | Residency, Department of Anesthesiology and Intensive Care, MHH (Directors: Prof. S. Piepenbrock/Prof. W. Koppert) |
| 2005 | License for Medical Practice (Approbation) |
Scientific career
| Since 07/2021 | PI, Collaborative Research Centre (SFB) PolyTarget (projects A02 and T01) (https://www.polytarget.uni-jena.de/en/news/bew%C3%A4hrtes+beibehalten+und+neues+wagen) |
| Since 09/2020 | University Professor at the Medical Faculty of the Friedrich Schiller University Jena |
| 2020 | Offer and acceptance of W2-professorship "Clinical Anaesthesiology and Translational Intensive Care Medicine", Medical Faculty of the Friedrich-Schiller-University Jena |
| 2019 | Offer and declination of W2-Professorship „Operative lntensive Medicine", Department of Medicine of the Philipps-University Marburg |
| Since 11/2016 | Head of the junior research group Translational Septomics at the ZIK Septomics (www.septomics.de/de/translational-septomics.html) with additional project funding by DFG and BMBF |
| Since 2015 | PI, Research Group 1738 (DFG) (www.hhdp.uni-jena.de/) |
| Since 2015 | PI, Center for Sepsis Control & Care (Integrated Research and Treatment Centers, BMBF) (www.cscc.uniklinikum-jena.de/CSCC.html) |
| Since 2014 | Junior Principal Investigator, Interdisciplinary Centre for Clinical Research (IZKF), University Hospital Jena (UKJ) |
| 2013 | Doctor of Philosophy (PhD), University of London, UK "Novel therapeutic strategies to reduce multiple organ dysfunction in experimental sepsis" |
| 2010 - 2013 | Fellow of the German Research Foundation and PhD student, Centre for Translational Medicine & Therapeutics (Head: Prof. C. Thiemermann),The William Harvey Research Institute, Queen Mary University of London, Barts & The London School of Medicine and Dentistry, UK |
| 2005 | Medical Doctor (MD) “The influence of the rpoS gene on the stress resistance of enterohemorrhagic Escherichia coli” (summa cum laude – passed with distinction) |
| 2002 - 2005 | MD student, Institute for Medical Microbiology and Hospital Epidemiology (Directors: Prof. D. Bitter-Suermann / Prof. S. Suerbaum), Hanover Medical School (MHH) |
Positions
| Since 2020 | (Co-)Editor of the journal intensive care medicine up2date (Georg Thieme Verlag) |
| Since 2020 | Member of the expert panel of the journal AINS (Georg Thieme Verlag) |
| Since 2017 | Member of the Editorial Board of "Shock" and „Frontiers in Immunology“ |
| Since 2016 | Member of the Board of ZIK Septomics |
| 2016 - 2018 | Member of te Board of the Center for Sepsis Control & Care (CSCC) |
| Since 2014 | Auditor of the European Shock Society |
Prizes and awards
| 2019 | Research Prize of the Charlotte Lehmann Foundation | ||
| 2015 | DGAI Research Fellowship of the Fresenius Foundation 2015 | ||
| 2014 | Hanseatic Doctoral Prize for experimental research in intensive and emergency medicine, Bremen | ||
| 2013 | Günther Schlag Memorial Award of the European Shock Society, Vienna | ||
| 2012 | DGAI Prize in the competition "Free Lectures" of the 14th Capital Congress of the DGAI for Anaesthesiology and Intensive Care Therapy, Berlin | ||
| 2012 | New Investigator Travel Award of the American Shock Society, Florida | ||
| 2005 | Promotional Prize of the Society of Friends of the MHH for the summer semester 2005 |
Coldewey SM, Neu C, Baumbach P, Scherag A, Goebel B, Ludewig K, Bloos F, Bauer M (2020) Identification of cardiovascular and molecular prognostic factors for the medium-term and long-term outcomes of sepsis (ICROS): protocol for a prospective monocentric cohort study. BMJ Open 10:e036527. doi: 10.1136/bmjopen-2019-036527
Stallmach A, Kortgen A, Gonnert F, Coldewey SM, Reuken P, Bauer M (2020) Infliximab against severe COVID-19-induced cytokine storm syndrome with organ failure-a cautionary case series. Crit Care. 24(1):444. doi: 10.1186/s13054-020-03158-0.
Neu C, Baumbach P, Plooij AK, Skitek K, Götze J, von Loeffelholz C, Schmidt-Winter C, Coldewey SM (2020) Non-Invasive Assessment of Mitochondrial Oxygen Metabolism in the Critically Ill Patient Using the Protoporphyrin IX‐Triplet State Lifetime Technique – a Feasibility Study. Front. Immunol. 11:757, https://doi.org/10.3389/fimmu.2020.00757
Dennhardt S, Finke KR, Huwiler A, Coldewey SM (2019) Sphingosine-1-phosphate promotes barrier-stabilizing effects in human microvascular endothelial cells via AMPK-dependent mechanisms. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1865(4):774-781. doi: 10.1016/j.bbadis.2018.12.022.
Coldewey SM, Rogazzo M, Collino M, Patel NS, Thiemermann C (2013) Inhibition of IκB kinase reduces the multiple organ dysfunction caused by sepsis in the mouse. Dis Model Mech. 2013, 6:1031-42. doi: 10.1242/dmm.012435.